Altamira Therapeutics CYTOF
OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Altamira Therapeutics (CYTOF) EBITDA (2013 - 2018)

Updated

Altamira Therapeutics' EBITDA was -$7.3 million in FY2019, compared with -$10.82 million in FY2018.

Analysis

Altamira Therapeutics (CYTOF) EBITDA (2013 - 2018) Analysis & Trends

From FY2015 onward, Altamira Therapeutics has reported EBITDA for 5 years.

  • The FY2019 figure marks the highest annual EBITDA in data going back to FY2015.
  • Per Business Quant data, EBITDA in earlier years was -$10.82 million in FY2018, -$24.63 million in FY2017, -$30.59 million in FY2016 and -$32.01 million in FY2015.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -547,567.64
Sep 30, 2018 -2.90 Mn
Jun 30, 2018 -3.14 Mn
Mar 31, 2018 -4.51 Mn
Dec 31, 2017 -5.48 Mn
Sep 30, 2017 -5.74 Mn
Jun 30, 2017 -6.02 Mn
Mar 31, 2017 -7.34 Mn
Dec 31, 2016 -6.29 Mn
Sep 30, 2016 -7.71 Mn
Jun 30, 2016 -9.25 Mn
Mar 31, 2016 -7.39 Mn
Dec 31, 2015 -6.82 Mn
Sep 30, 2015 -7.46 Mn
Jun 30, 2015 -10.30 Mn
Mar 31, 2015 -7.50 Mn
Dec 31, 2014 -5.79 Mn
Sep 30, 2014 -6.20 Mn
Jun 30, 2014 -5.66 Mn
Mar 31, 2014 -6.55 Mn
API Access

Altamira Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=CYTOF&period=max&api_key=YOUR_API_KEY